Neurologists’ Group Issues New Treatment Guidelines for Early Parkinson’s

neurologists group issues new treatment guidelines for early parkinsons

Sumary of Neurologists’ Group Issues New Treatment Guidelines for Early Parkinson’s:

  • 19, 2021 — Guidelines for treating movement problems in people in the early stages of Parkinson’s disease have been updated.
  • The guideline says neurologists should counsel patients on the benefits and risks of initial therapy with three treatment options: levodopa, a drug that is converted into dopamine in the brain;
  • Treatment with levodopa is better at reducing motor symptoms in early Parkinson’s patients than either dopamine agonists or MAO-B inhibitors, according to the guideline published online Nov.
  • The guideline says neurologists should prescribe the lowest effective dose of levodopa to maximize benefits and minimize dyskinesia risk.
  • While dopamine agonists are less likely to cause dyskinesia, they are more likely to cause impulse-control disorders, such as compulsive gambling, eating, shopping or sexual activity, as well as hallucinations, according to the guidelines.
  • They are also associated with a greater risk of excessive daytime sleepiness, so people with jobs that require driving or operating heavy machinery may face greater problems from these side effects, the guideline warns.

Want to know more click here go to source.

From -

Close

Site Language


Popular Posts

730

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close